Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 6/20 | 0.46 |
| ▸ | CTSK | P43235 | 6/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | PPARG | P37231 | 6/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12205389 | 0.88 | CTSK (0.43) | CTSSCTSKCTSLCTSBCA1 | |
| SCHEMBL1742210 | 0.85 | CTSK (0.50) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL646750 | 0.85 | CTSK (0.50) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL206031 | 0.85 | CTSK (0.50) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL24099502 | 0.84 | CTSS (0.48) | CTSSCTSKCTSLCTSBPPARA | |
| Hydrochloric Acid SCHEMBL14471562 | 0.83 | CTSK (0.49) | CTSSCTSKCTSLCTSBPPARA | |
| Hydrochloric Acid SCHEMBL16235893 | 0.83 | CTSK (0.49) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL26117886 | 0.82 | CTSS (0.49) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL26121244 | 0.82 | CTSS (0.49) | CTSSCTSKCTSLCTSBPPARA | |
| SCHEMBL26117881 | 0.82 | CTSS (0.49) | CTSSCTSKCTSLCTSBPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040249187-A1 | Method for producing chiral amino acid derivatives | BAYER CHEMICALS AG (DE) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249187-A1 | Method for producing chiral amino acid derivatives | ADH5, AADAT, NOS2 | CTSS 4651/4885CTSK 4469/4885CTSL 4392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.